Zhang Wenzhu, Liu Linlin, Zhao Shengdi, Chen Liang, Wei Yuxian, Chen Wenlin, Ge Fei
Department of Breast Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
No. 1 School of Clinical Medicine, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Oncol Lett. 2022 Apr;23(4):121. doi: 10.3892/ol.2022.13241. Epub 2022 Feb 14.
Breast cancer is the most common malignancy among women, and the abnormal regulation of gene expression serves an important role in its occurrence and development. However, the molecular mechanisms underlying gene expression are highly complex and heterogeneous, and RNA-binding proteins (RBPs) are among the key regulatory factors. RBPs bind targets in an environment-dependent or environment-independent manner to influence mRNA stability and the translation of genes involved in the formation, progression, metastasis and treatment of breast cancer. Due to the growing interest in these regulators, the present review summarizes the most influential studies concerning RBPs associated with breast cancer to elucidate the role of RBPs in breast cancer and to assess how they interact with other key pathways to provide new molecular targets for the diagnosis and treatment of breast cancer.
乳腺癌是女性中最常见的恶性肿瘤,基因表达的异常调控在其发生和发展中起着重要作用。然而,基因表达背后的分子机制高度复杂且具有异质性,而RNA结合蛋白(RBPs)是关键调控因子之一。RBPs以环境依赖或环境独立的方式结合靶标,以影响mRNA稳定性以及参与乳腺癌形成、进展、转移和治疗的基因的翻译。由于对这些调节因子的兴趣日益增加,本综述总结了有关与乳腺癌相关的RBPs的最具影响力的研究,以阐明RBPs在乳腺癌中的作用,并评估它们如何与其他关键途径相互作用,从而为乳腺癌的诊断和治疗提供新的分子靶点。